Demir, L., Akyol, M., Bener, S., Payzin, K.B., Erten, C., Somali, I., Can, A., Dirican, A., Bayoglu, V., Kucukzeybek, Y., Alacacioglu, A., Calli, A.O. and Tarhan, M.O. (2014) Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow Metastasis. Breast Journal, 20, 279-287.
https://doi.org/10.1111/tbj.12264

has been cited by the following article:

• TITLE: Predictive Value of Clinical and Laboratory Parameters for Overt Bone Marrow Metastasis in Patients with Solid Malignancy

  AUTHORS: Kalman Filanovsky, Edit Feldberg, Edward B. Miller, Lev Shvidel

  KEYWORDS: Bone Marrow Metastasis, Predictive Factors, Survival, Solid Tumor

  JOURNAL NAME: Journal of Cancer Therapy, Vol.8 No.8, August 10, 2017

  ABSTRACT: Bone marrow (BM) metastases are known to worsen the outcome in patients with malignancies and alter the choice of the treatment regimen. In an attempt to identify routine parameters for the prediction of BM metastasis we evaluated the clinical and laboratory data of 103 patients with metastatic solid tumors. We also assessed which of these factors appeared to influence survival. Three laboratory abnormalities were found to be predictive of metastasis on BM biopsy: thrombocytopenia 9/L OR 14.4; p = 0.02; hypocellular or dry tap aspirate OR 7.0; p = 0.02 and high serum alkaline phosphatase OR 6.5; p = 0.03. Three additional factors were found to be associated with deceased survival. Thrombocytopenia was associated with decreased survival from a median of 0.8 months to 4.1 months, p